Brawn Biotech Ltd
₹21.60
(0%)
Mon, 25 May 2026, 10:50 am
Health Technology
Pharmaceuticals: Major
24.5KBrawn Biotech Share Price Live Chart
1 Day
(0%)
No Result Found
Summary
Market Cap
5.70
Net Profit
-1.74
P/B
1.45
Sector P/E
34.11
P/E
0
EV/EBITDA
0
Debt/Equity (Industry)
0.52
Interest Cover (Industry)
0
ROCE (Industry)
0
RONW (Industry)
0
ROE
-41.33
ROCE
-18.71
Debt/Equity
0
EPS (TTM)
0.62
Dividend Yield
0
Book Value
10
Interest Cover
0
Analysis
all
- Brawn Biotech is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Brawn Biotech is profitable, therefore cash runway is not a concern.
- Brawn Biotech is profitable, therefore cash runway is not a concern.
- Brawn Biotech has no debt, it does not need to be covered by operating cash flow.
- Brawn Biotech has no debt, it does not need to be covered by short term assets.
- Unable to calculate sustainability of dividends as Brawn Biotech has not reported any payouts.
- Unable to evaluate Brawn Biotech's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Brawn Biotech's dividend against the top 25% market benchmark as the company has not reported any payouts.
- The average tenure for the Brawn Biotech board of directors is less than 3 years, this suggests a new board.
- The average tenure for the Brawn Biotech management team is less than 2 years, this suggests a new team.
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 52.94 | 53.39 | 53.66 | 53.66 | 53.66 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 |
| Public | 46.71 | 46.26 | 45.99 | 45.99 | 45.99 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 30.84 | 25.89 | 23.35 | 20.94 | 18.40 | 15.99 | 11.04 |
| Fibonacci | 25.89 | 24.00 | 22.83 | 20.94 | 19.05 | 17.88 | 15.99 |
| Camarilla | 22.16 | 21.71 | 21.25 | 20.94 | 20.35 | 19.89 | 19.44 |
Pivots Level: Classic
R3
+9.90
30.84
R2
+4.95
25.89
R1
+2.40
23.35
S1
-2.55
18.40
S2
-4.95
15.99
S3
-9.90
11.04
Moving Average
Period
Value
10-EMA
20.84
20-EMA
20.81
30-EMA
20.74
50-EMA
20.66
100-EMA
20.58
200-EMA
20.34
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 14 Nov 2025 | board-meetings | Quarterly Results | |
| 04 Sept 2025 | agm | ||
| 29 Aug 2024 | agm | ||
| 23 Aug 2023 | agm | ||
| 01 Sept 2022 | agm | ||
| 12 Aug 2021 | agm | ||
| 29 May 2018 | dividend | ₹1.00 Dividend /Share | 15 Sept 2018 |
| 30 May 2017 | dividend | ₹1.50 Dividend /Share | 16 Sept 2017 |
Peer Comparison
Brawn Biotech Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Divis Laboratories Ltd
Brawn Biotech Ltd About
Brawn Biotech Pharmaceutical Products cover all major product segments like Antibacterial, Cardiovascular, Antidiabetics, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Antiasthmatics, Antacids, Antimalarial, and Nutritionals. BRAWN
Industry
Trading
Founded
1985
Headquarters
CEO
B R Gupta
Employees
Contact
Website
http://www.brawnbiotech.com
solution@brawnbiotech.com
Phone
Location
C-64 Lajpat Nagar-1 1st Floor, , New Delhi, New Delhi, 110024
Brawn Biotech Ltd Company History
| Year | History |
|---|---|
| 1989 |
|
| 1993 |
|
| 2002 |
|
| 2007 |
|
| 2011 |
|